← Eichor
Study identifier: NCT06324422 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Exercise as Treatment of Fatigue in Parkinson´s Disease

Condition: Parkinson's Disease  ·  Sponsor: University of Aarhus

PhaseNA
Planned participants94
Who can joinAll sexes, 40 Years to no upper limit
Healthy volunteersNo

About this study

The primary goal of this study is to test whether 12 weeks of high-intensity aerobic exercise can treat fatigue in Parkinsons disease (PD). The study will be a randomized multi-site controlled trial with follow up. Clinically fatigued persons with PD will be allocated to either 12 weeks of high-intensity aerobic exercise or to a waitlist control group receiving high-intensity resistance exercise after 24 weeks of habitual lifestyle (control period). It is hypothesized that persons with PD receiving 12 weeks of high-intensity aerobic exercise will show superior effects on perceived fatigue (i.e., clinical relevant reductions) when compared to the PD control group (primary hypothesis), and that these effects are sustained after 12-weeks of follow up (secondary hypothesis).

This description comes directly from the study's public registry record.

Talk to the study team

Cecilie Thrue, PhD student  ·  +4520768102  ·  ceth@ph.au.dk

Ulrik Dalgas, Professor  ·  dalgas@ph.au.dk

Always discuss trial participation with your own doctor first.

Locations (1)

Exercise Biology, Dep. of Public Health, Aarhus UniversityAarhus, Central Jutland, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06324422